Quantcast
Last updated on April 16, 2014 at 12:11 EDT

Latest Upsher-Smith Laboratories Inc. Stories

2013-11-05 08:36:28

Multiple Presentations Highlight Progress of Epilepsy Program MAPLE GROVE, Minn., Nov. 5, 2013 /PRNewswire/ -- Upsher-Smith Laboratories, Inc. (Upsher-Smith), today announced that seven abstracts highlighting results from its Phase 3 (PREVAIL) clinical trial for USL255 (extended-release topiramate) have been accepted for presentation at the American Epilepsy Society's (AES) 67(th) Annual Meeting in Washington, DC, December 6-10, 2013. (Logo:...

2013-11-01 08:27:55

Findings Presented at 42nd Annual Child Neurology Society Meeting MAPLE GROVE, Minn., Nov. 1, 2013 /PRNewswire/ -- A new systematic review found that when compared with intravenous or rectally administered diazepam, intranasal midazolam was equally effective and demonstrated comparable safety for the treatment of acute seizure emergencies in pediatric patients. Findings from the systematic review were presented at the 42(nd) Annual Child Neurology Society meeting in Austin, Texas, October 30...

2013-10-15 12:31:39

Findings Support Tolerability and Consistent Pharmacokinetic Profile of Once-Daily USL255 MAPLE GROVE, Minn., Oct. 15, 2013 /PRNewswire/ -- Upsher-Smith Laboratories, Inc., (Upsher-Smith) announced the presentation of Phase 1 data supporting the favorable tolerability and consistent, predictable pharmacokinetic (PK) profile of its investigational drug, USL255 (extended-release topiramate) following single-dose administration to healthy subjects. USL255 is being developed by...

2013-09-30 16:25:24

MAPLE GROVE, Minn., Sept. 30, 2013 /PRNewswire/ -- Upsher-Smith Laboratories, Inc. (Upsher-Smith), a fully integrated pharmaceutical company committed to the development of new treatments for diseases of the central nervous system, today announced that its UK subsidiary, Proximagen Limited, has entered into a preclinical development agreement with Denmark-based H. Lundbeck A/S (Lundbeck) to further its research program related to protein kinase inhibitors. This transaction is part of...

2013-09-04 12:32:25

MAPLE GROVE, Minn., Sept. 4, 2013 /PRNewswire/ -- September is National Cholesterol Education Month and leading cardiologist Dr. Carl Lavie, Medical Director of Cardiac Rehabilitation and Prevention at the John Ochsner Heart and Vascular Institute, New Orleans, LA, urges all Americans to know the basic facts about cholesterol management. A recent study from the Centers for Disease Control and Prevention reports that awareness about the importance of cholesterol management is on the...

2013-08-29 16:25:25

MAPLE GROVE, Minn., Aug. 29, 2013 /PRNewswire/ -- Upsher-Smith Laboratories, Inc., today announced its Morphine Sulfate Extended-Release Capsules, CII will be commercially available on September 4, 2013. (Logo: http://photos.prnewswire.com/prnh/20130520/NY17281LOGO ) Historically, there have been a limited number of morphine sulfate generics available. Upsher-Smith used its extensive formulation experience to overcome the challenges presented. Upsher-Smith's family of Morphine...

2013-08-16 16:22:14

MAPLE GROVE, Minn., Aug. 16, 2013 /PRNewswire/ -- Upsher-Smith Laboratories, Inc., today announced that it has received tentative approval from the U.S. Food and Drug Administration (FDA) for its New Drug Application (NDA) for Vogelxo(TM) (testosterone) gel for topical use CIII. (Logo: http://photos.prnewswire.com/prnh/20130520/NY17281LOGO ) About Upsher-Smith Upsher-Smith, founded in 1919, is an independent and privately-owned specialty pharmaceutical company...

2013-08-13 08:30:52

Showed Reduced Fluctuations of Topiramate Steady-State Plasma Concentrations and was Well Tolerated in Healthy Volunteers MAPLE GROVE, Minn., Aug. 13, 2013 /PRNewswire/ -- Upsher-Smith Laboratories, Inc.'s, USL255 (extended-release topiramate), an investigational once-daily formulation for the management of epilepsy, demonstrated equivalent systemic exposure with an improved topiramate (TPM) pharmacokinetic (PK) profile at steady-state, as measured by a significantly lower C(max)...

2013-08-09 16:22:24

Campaign to Raise Awareness for Epilepsy in Minnesota and North Dakota MAPLE GROVE, Minn., Aug. 9, 2013 /PRNewswire/ -- Upsher-Smith Laboratories, Inc., today announced that it teamed up with the Epilepsy Foundation of Minnesota to support those with epilepsy at the 15(th) annual Stroll for Epilepsy. The Stroll took place on Thursday, August 8, 2013 in five cities throughout Minnesota and North Dakota to benefit those with epilepsy. The two-mile walk is the largest fundraising and...

2013-08-07 12:27:08

MAPLE GROVE, Minn., Aug. 7, 2013 /PRNewswire/ -- There has been a great deal of media coverage surrounding heart health and niacin, leaving some consumers confused about its benefits, according to leading cardiologist, Dr. Carl Lavie, Medical Director of Cardiac Rehabilitation and Prevention at the John Ochsner Heart and Vascular Institute, New Orleans, LA. For cholesterol-conscious consumers who are serious about optimizing heart health, Dr. Lavie stands by his long-term...